directonpc
Ebola Vaccine tested on monkeys and Worked!
(Aug 25 2014 at 10:00pm)
Nova Scotia - Four monkeys survived the Ebola virus after
being injected with Immunovaccine Inc's experimental
vaccine, the tiny Canadian company said on Monday, an
announcement that sent its stock soaring.
The Halifax, Nova Scotia-based company said four monkeys
received its vaccine and later survived a dose of Ebola virus
that normally would have been lethal. Two other animals
that did not receive the vaccine died within a week.
Also read: The new Ebola vaccine - some details
The tests were performed by the U.S. Health Department's
National Institutes of Health, based in Maryland.
Immunovaccine, which had a market capitalization of about
C$77 million as of Friday, is one of a handful of companies
testing potential vaccines for the Ebola virus, which has
killed nearly 1,500 people in West Africa.
Other companies testing Ebola vaccines include U.S.-based
NewLink Genetics Corp, which holds the licence for a
vaccine developed by the Canadian government, and
privately held Profectus BioSciences.
Immunovaccine said it is exploring options to develop the
vaccine with various organizations. The company is also
developing therapies for cancer and a vaccine for anthrax.
Its stock on the TSX Venture Exchange jumped as much as
44 percent, and was up 26.8 percent at C$1.23 around
midday, after a trading halt.
source news24
[1K views]
Last edited 25 Aug 2014
You may also Like:
